Axa’s Everpure Inc P Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-15,829
Closed -$972K 1126
2024
Q4
$972K Sell
15,829
-2,112
-12% -$118K ﹤0.01% 872
2024
Q3
$901K Buy
17,941
+3,877
+28% +$219K ﹤0.01% 890
2024
Q2
$903K Buy
+14,064
New +$814K ﹤0.01% 887
2024
Q1
Sell
-29,100
Closed -$1.04M 1105
2023
Q4
$1.04M Sell
29,100
-176,800
-86% -$6.2M ﹤0.01% 839
2023
Q3
$7.33M Buy
205,900
+25,900
+14% +$960K 0.03% 450
2023
Q2
$6.63M Buy
+180,000
New +$5.1M 0.02% 490
2023
Q1
Sell
-33,200
Closed -$888K 1169
2022
Q4
$888K Sell
33,200
-40,900
-55% -$1.19M ﹤0.01% 905
2022
Q3
$2.03M Buy
+74,100
New +$2.09M 0.01% 755
2022
Q2
Sell
-17,500
Closed -$618K 1190
2022
Q1
$618K Hold
17,500
﹤0.01% 1016
2021
Q4
$570K Buy
+17,500
New +$508K ﹤0.01% 1012
2021
Q2
Sell
-130,099
Closed -$2.8M 1290
2021
Q1
$2.8M Sell
130,099
-16,653
-11% -$396K 0.01% 798
2020
Q4
$3.32M Buy
146,752
+19,320
+15% +$370K 0.01% 774
2020
Q3
$1.96M Sell
127,432
-321,000
-72% -$5.25M 0.01% 812
2020
Q2
$7.77M Sell
448,432
-405,821
-48% -$6.08M 0.03% 497
2020
Q1
$10.5M Buy
854,253
+23,935
+3% +$388K 0.05% 355
2019
Q4
$14.2M Buy
830,318
+96,065
+13% +$1.7M 0.06% 364
2019
Q3
$12.4M Hold
734,253
0.05% 412
2019
Q2
$11.2M Sell
734,253
-217,769
-23% -$4.25M 0.04% 443
2019
Q1
$20.7M Buy
952,022
+38,250
+4% +$727K 0.08% 298
2018
Q4
$14.7M Buy
913,772
+53,300
+6% +$1.05M 0.06% 339
2018
Q3
$22.3M Buy
860,472
+52,730
+7% +$1.31M 0.08% 276
2018
Q2
$19.3M Buy
807,742
+412,742
+104% +$9.07M 0.07% 295
2018
Q1
$7.88M Hold
395,000
0.03% 524
2017
Q4
$6.26M Buy
395,000
+48,300
+14% +$805K 0.02% 601
2017
Q3
$5.54M Buy
346,700
+29,700
+9% +$407K 0.02% 600
2017
Q2
$4.06M Buy
317,000
+97,000
+44% +$1.13M 0.02% 651
2017
Q1
$2.16M Buy
+220,000
New +$2.44M 0.01% 767

Other funds holding P

Axa's P Position: Q1 2025 in Review

Axa sold out of Everpure Inc (P) in Q1 2025, closing a stake of 15,829 shares — an estimated $972K sold.

Axa first reported a position in P in Q1 2017 and held it in 27 quarters. The position peaked at $22.3M in Q3 2018. 648 funds tracked by Wall St. Rank hold P as of Q1 2025.

  • Axa reported no remaining Everpure Inc position as of Q1 2025 after selling out during the quarter.
  • Axa sold 15,829 Everpure Inc shares in Q1 2025, an estimated $972K.
  • Axa first reported a position in Everpure Inc in Q1 2017 and held it in 27 quarters.
  • Axa's Everpure Inc position peaked at $22.3M in Q3 2018.
  • 648 funds tracked by Wall St. Rank held Everpure Inc as of Q1 2025.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.